CD8A and neoplasm: In metastatic pancreatic cancer, DCs induce the proliferation of Treg cells and inhibit CD8+ T cell-mediated tumor immunity via MGL2 and PD-L2, establishing an immunosuppressive microenvironment favor for metastasis formation (114).